Back to Search
Start Over
A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3.
- Source :
-
Rheumatology international [Rheumatol Int] 2020 Jul; Vol. 40 (7), pp. 1081-1087. Date of Electronic Publication: 2020 Jan 25. - Publication Year :
- 2020
-
Abstract
- The aim of this study was to assess changes in the estimated glomerular filtration rate (eGFR) in gouty patients with chronic kidney disease (CKD) using a "treat-to-target" (T2T) approach in gout. This multicenter observational retrospective study included patients diagnosed with gout and CKD stage 3 taking xanthine oxidase inhibitors (XOIs) (allopurinol or febuxostat) for at least 12 months. All patients were treated using a T2T strategy according to national gout guidelines to achieve the target levels of serum uric acid (sUA; < 5-6 mg/dl) within 6 months of the first visit. The primary outcome was to assess changes in eGFR. The effects of independent variables were analyzed over eGFR in a linear mixed-effects (LME) model. Fifty patients with gout and CKD stage 3 treated with XOIs with a T2T strategy for 12 months were included. Eighty-two percent of the patients achieved the sUA target during the study period. The improvement seen in eGFR was higher during the first 6 months, showing a median increase of 7.54 ml/min/m <superscript>2</superscript> (SE = 1.25) and trending towards stability over 12 months. For every 1 mg/dl of decrease in sUA, an improvement of 1.5 ml/min/m <superscript>2</superscript> in eGFR was observed (coefficient ± SE: - 1.58 ± 0.26) (p < 0.001) with no differences between type and dosage of XOIs treatment, colchicine administration, age, sex, and smoking status. A reduction in sUA levels using a T2T approach with XOIs at an optimal dose is possible and could help conserve and improve renal function in gouty patients with CKD stage 3.
- Subjects :
- Aged
Aged, 80 and over
Alcohol Drinking
Colchicine therapeutic use
Female
Gout blood
Gout complications
Humans
Linear Models
Male
Middle Aged
Patient Care Planning
Renal Insufficiency, Chronic complications
Retrospective Studies
Smoking
Treatment Outcome
Uric Acid blood
Xanthine Oxidase antagonists & inhibitors
Allopurinol therapeutic use
Febuxostat therapeutic use
Glomerular Filtration Rate
Gout drug therapy
Gout Suppressants therapeutic use
Renal Insufficiency, Chronic metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1437-160X
- Volume :
- 40
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Rheumatology international
- Publication Type :
- Academic Journal
- Accession number :
- 31982955
- Full Text :
- https://doi.org/10.1007/s00296-020-04517-4